Professor Bart Fauser is Emeritus Professor of Reproductive Medicine at the University of Utrecht, a world leader in reproductive medicine and has had a profound influence on modern clinical practice, training and inspiring a generation of researchers and new leaders in the field. He gives us his impressions of the meeting he attended in Melbourne and provides us with some sound advice for the CRE moving forward.
It has been a great pleasure to be invited to attend this important internal review meeting, as chair of the CRE International Advisory board. To be surrounded by around 50 colleagues with a profound research interest in PCOS has been a real treat. The open and friendly atmosphere made the event even more enjoyable. Indeed, the CRE guidelines will dominate PCOS care and research for the years to come, and you can all be proud for getting this all together with so many players around the world.
I would also like to share with you my observations as a relative outsider:
- Much research presented was mono-disciplinary. There seems room for more multi-disciplinary approaches.
- Much research presented focused on Australia only. There seems much room for more international collaboration.
- Contemporary genetics in the context of PCOS needs to be addressed.
- So far there has been limited attention for pregnancy complications, perinatal outcomes and children follow-up in PCOS. This needs consideration.
- It seems difficult to obtain funding for PCOS research in Australia, like everywhere else. It may be useful to explore the options for obtaining funding under another heading, like – for instance – healthy aging, female cardiovascular or metabolic disease, future health of children and so on.
Professor Fauser made a significant sacrifice to attend our small meeting without reward or favour; and to give us more time to write a piece for our newsletter is testimony to the commitment he has to his work. Bart has raised many questions which will provide focus throughout the remainder of this CRE in PCOS, and for the next one.
“The CRE guidelines will dominate PCOS care and research for the years to come,” Professor Bart Fauser